Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:glatiramer_acetate
|
| gptkbp:approvalYear |
1996
|
| gptkbp:ATCCode |
gptkb:L03AX13
|
| gptkbp:form |
injection
20 mg/mL 40 mg/mL |
| gptkbp:frequency |
daily
three times per week |
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Copaxone
|
| gptkbp:indication |
relapsing-remitting multiple sclerosis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:patentExpired |
yes
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
injection site reaction
shortness of breath chest pain palpitations flushing |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:bfsLayer |
5
|